Compugen Stock

Compugen Non-Current Assets

The Non-Current Assets of Compugen (CGEN) as of Sep 7, 2026 is -147.73 M USD. In the previous year, Non-Current Assets was -106.00 M USD — a change of 39.37% (lower).

Non-Current Assets

-147.73 MUSD

YoY

39.37%

Last updated:

Non-Current Assets of Compugen is 2026 -147.73 M USD. Non-Current Assets of Compugen was 2025 -106.00 M USD. It decreases by 39.37% lower compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Non-Current Assets of Compugen is -147.73 M USD in 2026.

Non-Current Assets of Compugen changed from -106.00 M USD to -147.73 M USD, representing a 39.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Non-Current Assets Compugen since 2006 – with annual values, charts, and detailed analysis.

Non-current assets are long-term resources not expected to be converted to cash within one year, including property, equipment, and long-term investments.

Non-Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Non-Current Assets's Compugen historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Compugen

All Key Metrics — Compugen